Latest media releases

UBS Hires Bruce Nudell as Senior Healthcare Analyst

New York Media Releases Americas

UBS today announced that Bruce Nudell has joined the firm as Managing Director and Senior Healthcare Analyst within US Equity Research at UBS Investment Bank, covering medical supplies and devices companies. He is based in New York and reports to Mark Altman, Head of US Equity Research.

"Bruce's career experience as an analyst as well as in the medical field makes him a valuable addition to the Health Care team," said Altman. "As the medical supplies and devices sector continues to evolve and consolidate, we are dedicated to providing our clients with insightful research and unique and forward-thinking investment ideas."

Prior to joining UBS, Nudell was a Senior Healthcare Research Analyst at Sanford Bernstein. Before becoming an analyst, Nudell was Vice President for business development and strategic planning with Datex Ohmeda, a provider of anesthesia and critical care solutions.

Nudell earned his PhD in Cellular Electrophysiology from UCLA, his Master's in Finance from the University of Colorado and his B.A. in Bio-Geography from Northwestern.

UBS is one of the world's leading financial firms, serving a discerning international client base. Its business, global in scale, is focused on growth. As an integrated firm, UBS creates added value for clients by drawing on the combined resources and expertise of all its businesses.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking.

UBS is present in all major financial centers worldwide. It has offices in 50 countries, with about 39% of its employees working in the Americas, 34% in Switzerland, 17% in the rest of Europe and 10% in Asia Pacific. UBS's financial businesses employ some 80,000 people around the world. Its shares are listed on the SWX Swiss Stock Exchange, the New York Stock Exchange (NYSE) and the Tokyo Stock Exchange (TSE).


Allison Chin-Leong: +1-212-882-5693

New York, June 26, 2007